Diabetes, Vol 34, Issue 3 246-250, Copyright © 1985 by American Diabetes Association

ARTICLES

Do pancreatic islets contain significant amounts of phosphoenolpyruvate carboxykinase or ferroactivator activity?

MJ MacDonald and CM Chang

Phosphoenolpyruvate carboxykinase activity was measured in rat pancreatic islet cytosol and mitochondria. No carboxykinase activity was detected under a variety of conditions, including those that increase phosphoenolpyruvate carboxykinase activity in nonislet tissues, such as starving animals or incubating the islet extracts with Fe2+ or Mn2+ before assaying for enzyme activity. The amounts of islet cytosol protein used exceeded those of liver in companion assays used as controls. It was calculated that if islet phosphoenolpyruvate carboxykinase activity was 0.005 that of liver, or 1 X 10(-5) as high as pyruvate kinase activity in islets, it should have been detected in the assays used. Ferroactivator is a protein that permits Fe2+ to activate phosphoenolpyruvate carboxykinase and it is ubiquitous to many tissues that do and even do not contain the carboxykinase. Ferroactivator activity was not detectable in pancreatic islets. Pyruvate kinase, an enzyme that catalyzes a reaction that is essentially the opposite of that catalyzed by phosphoenolpyruvate carboxykinase (i.e., phosphoenolpyruvate formation), is plentiful in islet cytosol. Therefore, even if phosphoenolpyruvate carboxykinase activity is present in pancreatic islets, it is so low that it is unlikely that phosphoenolpyruvate formation would be favored and the contribution of the carboxykinase to intracellular carbohydrate metabolism must be quantitatively unimportant.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				E. Heart and P. J. S. Smith Rhythm of the beta-cell oscillator is not governed by a single regulator: multiple systems contribute to oscillatory behavior Am J Physiol Endocrinol Metab, May 1, 2007; 292(5): E1295 - E1300. [Abstract] [Full Text] [PDF]

				R. L. Pongratz, R. G. Kibbey, G. I. Shulman, and G. W. Cline Cytosolic and Mitochondrial Malic Enzyme Isoforms Differentially Control Insulin Secretion J. Biol. Chem., January 5, 2007; 282(1): 200 - 207. [Abstract] [Full Text] [PDF]

				M. J. MacDonald, L. A. Fahien, L. J. Brown, N. M. Hasan, J. D. Buss, and M. A. Kendrick Perspective: emerging evidence for signaling roles of mitochondrial anaplerotic products in insulin secretion Am J Physiol Endocrinol Metab, January 1, 2005; 288(1): E1 - E15. [Abstract] [Full Text] [PDF]

				G. W. Cline, R. L. LePine, K. K. Papas, R. G. Kibbey, and G. I. Shulman 13C NMR Isotopomer Analysis of Anaplerotic Pathways in INS-1 Cells J. Biol. Chem., October 22, 2004; 279(43): 44370 - 44375. [Abstract] [Full Text] [PDF]

				A.-K. Parkkila, A. L. Scarim, S. Parkkila, A. Waheed, J. A. Corbett, and W. S. Sly Expression of Carbonic Anhydrase V in Pancreatic Beta Cells Suggests Role for Mitochondrial Carbonic Anhydrase in Insulin Secretion J. Biol. Chem., September 18, 1998; 273(38): 24620 - 24623. [Abstract] [Full Text] [PDF]

				F. Schuit, A. De Vos, S. Farfari, K. Moens, D. Pipeleers, T. Brun, and M. Prentki Metabolic Fate of Glucose in Purified Islet Cells. GLUCOSE-REGULATED ANAPLEROSIS IN beta  CELLS J. Biol. Chem., July 25, 1997; 272(30): 18572 - 18579. [Abstract] [Full Text] [PDF]

				R. J. Mertz, J. F. Worley III, B. Spencer, J. H. Johnson, and I. D. Dukes Activation of Stimulus-Secretion Coupling in Pancreatic beta-Cells by Specific Products of Glucose Metabolism J. Biol. Chem., March 1, 1996; 271(9): 4838 - 4845. [Abstract] [Full Text] [PDF]

				M. J. MacDonald and M. J. MacDonald Feasibility of a Mitochondrial Pyruvate Malate Shuttle in Pancreatic Islets J. Biol. Chem., August 25, 1995; 270(34): 20051 - 20058. [Abstract] [Full Text] [PDF]